December 16, 2014 — Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
December 16, 2014
November 25, 2014 — Between 70 and 80 percent of patients with the connective tissue condition Marfan syndrome have ...
November 25, 2014
November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...
November 24, 2014November 12, 2014 — The actions — or inaction — of patients should be considered in programs designed to improve care ...
November 12, 2014
October 20, 2014 – Heart disease and stroke are the leading causes of death and disability among people with Type 2 ...
October 20, 2014October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...
October 15, 2014October 14, 2014 — Researchers have discovered a previously unknown cardiac molecule that could provide a key to ...
October 14, 2014September 23, 2014 — New analyses and extended follow-up from the BRIGHT study demonstrated that bivalirudin remained ...
September 23, 2014September 22, 2014 — According to a new study, patients receiving six months of dual antiplatelet therapy (DAPT) after ...
September 22, 2014
September 19, 2014 — The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers ...
September 19, 2014
September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug ...
September 19, 2014
September 12, 2014 — The first researcher in the world to discover that aspirin prevents a first attack, Charles H ...
September 12, 2014
September 3, 2014 –In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable ...
September 03, 2014
September 2, 2014 – Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare ...
September 02, 2014
August 28, 2014 — The American College of Cardiology and the American Heart Association today released a revised ...
August 28, 2014